Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: Success stories from two private pediatric clinics-Reference-Cited by-同舟云学术

Multi-level quality improvement strategies to optimize HPV vaccination starting at the 9-year well child visit: Success stories from two private pediatric clinics

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zorn Sherri¹,Darville - Sanders Gabrielle²,Vu Thuy³,Carter Amy⁴,Treend Katie⁵,Raunio Char⁶,Vasavada Anjali³

Affiliation:

1. Pediatrics Department, Optum Washington, Seattle, WA, USA

2. The National HPV Vaccination Roundtable, American Cancer Society, Kennesaw, GA, USA

3. School of Public Health, University of Washington Health Promotion Research Center, Seattle, WA, USA

4. Allegro Pediatrics, Bellevue, WA, USA

5. Comprehensive Cancer Control Program, Washington State Department of Health, Tumwater, WA, USA

6. Cancer Support Strategic Partnerships, American Cancer Society, Seattle, WA, USA

Funder

Amerigroup Washington, Inc

WA DOH

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2163807

Reference29 articles.

1. Centers for Disease Control and Prevention U.S. Department of Health and Human Services. U.S. Cancer statistics data brief: cancers associated with human papillomavirus United States – 2014–2018; 2021 Dec [accessed 2022 Jul 1]. https://www.cdc.gov/cancer/uscs/pdf/USCS-DataBrief-No26-December2021-h.pdf.

2. US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines

3. U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion. Healthy people 2030 [accessed 2022 Sep 9]. https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/increase-proportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08/data.

4. National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2021

5. Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPV vaccine standing orders and communication in primary care: A qualitative study;Vaccine;2024-07

2. Effect of an HPV Vaccination Multi-Level, Multi-Component Program on HPV Vaccination Initiation and Completion in a Pediatric Clinic Network;Vaccines;2024-05-08

3. Impact of visit characteristics on intention to recommend HPV vaccine: An experiment with US health care professionals;Preventive Medicine;2024-02

4. Mothers’ perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds;Human Vaccines & Immunotherapeutics;2023-11-13

5. Effect of immunization registry-based provider reminder to initiate HPV vaccination at age 9, Washington state;Human Vaccines & Immunotherapeutics;2023-11-06